Rafael Marcos Gragera-rekin lankidetzan egindako argitalpenak (69)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

  2. Differences in survival and recurrence of colorectal cancer by stage across population-based European registries

    International Journal of Cancer, Vol. 155, Núm. 5, pp. 807-815

  3. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

    The Lancet Oncology, Vol. 25, Núm. 6, pp. 731-743

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

  2. Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment

    Cancers, Vol. 15, Núm. 24

  3. Circulating miRNAs signature on breast cancer: the MCC-Spain project

    European Journal of Medical Research, Vol. 28, Núm. 1

  4. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain)

    International Journal of Cancer, Vol. 153, Núm. 5, pp. 979-993

  5. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes

    Frontiers in Oncology, Vol. 13

  6. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606

  7. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

  8. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018

    Frontiers in Oncology, Vol. 13

2022

  1. Association of time of breakfast and nighttime fasting duration with breast cancer risk in the multicase-control study in Spain

    Frontiers in Nutrition, Vol. 9

  2. Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN)

    Cancers, Vol. 14, Núm. 10

  3. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

    Frontiers in Oncology, Vol. 12

  4. Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

    Cancer Causes and Control, Vol. 33, Núm. 1, pp. 125-136

  5. Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study

    Menopause (New York, N.Y.), Vol. 29, Núm. 11, pp. 1315-1322

  6. Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

    Frontiers in Oncology, Vol. 12

  7. Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries

    Scientific Reports, Vol. 12, Núm. 1

  8. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 8, pp. 711-723

  9. Sleep and breast and prostate cancer risk in the MCC-Spain study

    Scientific Reports, Vol. 12, Núm. 1